References

1. Zhang, J., et al., Resurgence of H5N6 avian influenza virus in 2021 poses new threat to public health. The Lancet Microbe, 2022.
2. Mishin, V.P., et al., Susceptibility of influenza A, B, C, and D viruses to baloxavir. Emerging infectious diseases, 2019.25 (10): p. 1969.
3. Neumann, G., T. Noda, and Y. Kawaoka, Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature, 2009.459 (7249): p. 931-939.
4. Influenza, W.C.o.t.W.C.o.C.A.o.P., Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. New England Journal of Medicine, 2010. 362 (18): p. 1708-1719.
5. Reed, C., et al., Estimates of the prevalence of pandemic (H1N1) 2009, United States, April–July 2009. Emerging infectious diseases, 2009. 15 (12): p. 2004.
6. Team, N.S.-O.I.A.V.I., Emergence of a novel swine-origin influenza A (H1N1) virus in humans. New England journal of medicine, 2009. 360 (25): p. 2605-2615.
7. Organization, W.H., Mathematical modelling of the pandemic H1N1 2009. Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire, 2009. 84 (34): p. 341-348.
8. Investigators, A.I., Critical care services and 2009 H1N1 influenza in Australia and New Zealand. New England Journal of Medicine, 2009. 361 (20): p. 1925-1934.
9. Louie, J.K., et al., Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. Jama, 2009. 302 (17): p. 1896-1902.
10. Mauad, T., et al., Lung pathology in fatal novel human influenza A (H1N1) infection. American journal of respiratory and critical care medicine, 2010. 181 (1): p. 72-79.
11. Li, P., et al., Serial evaluation of high-resolution CT findings in patients with pneumonia in novel swine-origin influenza A (H1N1) virus infection. The British Journal of Radiology, 2012.85 (1014): p. 729-735.
12. Jain, S., et al., Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. New England journal of medicine, 2009. 361 (20): p. 1935-1944.
13. Vaillant, L., et al., Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Eurosurveillance, 2009.14 (33): p. 19309.
14. Van Kerkhove, M.D., et al., Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis.PLoS medicine, 2011. 8 (7): p. e1001053.
15. Donaldson, L.J., et al., Mortality from pandemic A/H1N1 2009 influenza in England: a public health surveillance study. Bmj, 2009.339 .
16. Flegal, K.M., et al., Excess deaths associated with underweight, overweight, and obesity. Jama, 2005. 293 (15): p. 1861-1867.
17. Organization, W.H., WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. 2009.
18. Confalonieri, M., et al., Methylprednisolone infusion for life-threatening H1N1-virus infection. Therapeutic Advances in Respiratory Disease, 2010. 4 (4): p. 233-237.
19. Perez-Padilla, R., et al., Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. New England journal of medicine, 2009. 361 (7): p. 680-689.
20. Organization, W.H., Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire, 2009. 84 (21): p. 185-189.
21. Kumar, A., et al., Critically ill patients with 2009 influenza A (H1N1) infection in Canada. Jama, 2009. 302 (17): p. 1872-1879.
22. Bewick, T., S. Greenwood, and W.S. Lim, What is the role of pulse oximetry in the assessment of patients with community-acquired pneumonia in primary care? Primary Care Respiratory Journal, 2010.19 (4): p. 378-382.
23. Hann, H.-W., et al., Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients. PloS one, 2012. 7 (10): p. e47687.
24. Li, P., et al., Serial evaluation of high-resolution CT findings in patients with pneumonia in novel swine-origin influenza A (H1N1) virus infection. The British journal of radiology, 2012.85 (1014): p. 729-735.